Inohara H - Search Results

1

Endoscopic examination of the upper gastrointestinal tract for the presence of second primary cancers in head and neck cancer patients.

Okumura T, Aruga H, Inohara H, Matsunaga T, Shiozaki H, Kobayashi K, Kubo K, Yoshida J. Okumura T, et al. Among authors: inohara h. Acta Otolaryngol Suppl. 1993;501:103-6. doi: 10.3109/00016489309126227. Acta Otolaryngol Suppl. 1993. PMID: 7680519

2

Growth and metastasis of fresh human benign and malignant tumors in the head and neck regions transplanted into scid mice.

Inohara H, Matsunaga T, Nomura T. Inohara H, et al. Carcinogenesis. 1992 May;13(5):845-9. doi: 10.1093/carcin/13.5.845. Carcinogenesis. 1992. PMID: 1586997

3

Reduction of leaky lymphocyte clones producing immunoglobulins and thymic lymphocytic leukemia by selective inbreeding of SCID (severe combined immunodeficiency) mice.

Inohara H, Nomura T, Hongyo T, Nakajima H, Kawaguchi T, Fukuda K, Sutoh K, Iwasa T, Matsunaga T. Inohara H, et al. Acta Otolaryngol Suppl. 1993;501:107-10. doi: 10.3109/00016489309126228. Acta Otolaryngol Suppl. 1993. PMID: 8447219

4

Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.

Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T. Inohara H, et al. Cancer. 1999 Jun 1;85(11):2475-84. Cancer. 1999. PMID: 10357421 Clinical Trial.

5

Association of p53 expression with second primary tumour development in hypopharyngeal carcinoma.

Hattori K, Inohara H, Sawada T, Honjo Y, Yoshida J, Kubo T. Hattori K, et al. Among authors: inohara h. J Laryngol Otol. 2000 Mar;114(3):198-201. doi: 10.1258/0022215001905328. J Laryngol Otol. 2000. PMID: 10829108

6

Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.

Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T. Honjo Y, et al. Among authors: inohara h. Clin Cancer Res. 2000 Dec;6(12):4635-40. Clin Cancer Res. 2000. PMID: 11156213

7

Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma.

Oji Y, Inohara H, Nakazawa M, Nakano Y, Akahani S, Nakatsuka S, Koga S, Ikeba A, Abeno S, Honjo Y, Yamamoto Y, Iwai S, Yoshida K, Oka Y, Ogawa H, Yoshida J, Aozasa K, Kubo T, Sugiyama H. Oji Y, et al. Among authors: inohara h. Cancer Sci. 2003 Jun;94(6):523-9. doi: 10.1111/j.1349-7006.2003.tb01477.x. Cancer Sci. 2003. PMID: 12824878 Free PMC article.

8

The role of fine-needle aspiration cytology and magnetic resonance imaging in the management of parotid mass lesions.

Inohara H, Akahani S, Yamamoto Y, Hattori K, Tomiyama Y, Tomita Y, Aozasa K, Kubo T. Inohara H, et al. Acta Otolaryngol. 2008 Oct;128(10):1152-8. doi: 10.1080/00016480701827533. Acta Otolaryngol. 2008. PMID: 18607904

9

The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.

Inohara H, Enomoto K, Tomiyama Y, Yoshii T, Osaki Y, Higuchi I, Inoue T, Hatazawa J. Inohara H, et al. Acta Otolaryngol. 2009 Aug;129(8):893-9. doi: 10.1080/00016480802441747. Acta Otolaryngol. 2009. PMID: 18839385

10

Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.

Hanamoto A, Takenaka Y, Shimosegawa E, Ymamamoto Y, Yoshii T, Nakahara S, Hatazawa J, Inohara H. Hanamoto A, et al. Among authors: inohara h. Ann Nucl Med. 2013 Dec;27(10):880-5. doi: 10.1007/s12149-013-0765-x. Epub 2013 Aug 25. Ann Nucl Med. 2013. PMID: 23979967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters